Lifecore Biomedical
LFCR
LFCR
93 hedge funds and large institutions have $275M invested in Lifecore Biomedical in 2021 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 35 increasing their positions, 38 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 96 → 93 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
66% less call options, than puts
Call options by funds: $45K | Put options by funds: $134K
Holders
93
Holding in Top 10
2
Calls
$45K
Puts
$134K
Top Buyers
| 1 | +$6.29M | |
| 2 | +$1.22M | |
| 3 | +$1.06M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.06M |
| 5 |
BlackRock
New York
|
+$1.04M |
Top Sellers
| 1 | -$3.51M | |
| 2 | -$2.91M | |
| 3 | -$2.76M | |
| 4 |
Morgan Stanley
New York
|
-$1.92M |
| 5 |
HFA
Harbert Fund Advisors
Birmingham,
Alabama
|
-$1.65M |